Commentary
See article on page 122Cryoglobulinaemia in HCV infection: coming in from the cold
| The first 150 words of the full text of this article appear below. |
Hepatitis C virus (HCV) antibodies are detected in up to 1.5% of blood donors worldwide and HCV is estimated to infect at least 4 million people in the USA alone.1 HCV is probably the commonest cause of liver disease and hepatocellular carcinoma in the developed world and has become the leading reason for liver transplantation in many centres. HCV is thought to be the aetiological factor in the majority of cases of mixed cryoglobulinaemia in which HCV RNA is concentrated in high titre in cryoprecipitates.2 Conversely, up to 54% of patients with HCV infection have detectable cryoglobulins, which are associated with symptoms in roughly 25%, most commonly including cutaneous manifestations and arthralgias but much less often glomerulonephritis and neurological abnormalities.3 Although some studies have noted a correlation between the severity of liver disease and the level of cryoglobulins in serum, this has not been a consistent observation.
In this issue (see
Relevant Article
-
Response to interferon
treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus
- P Cresta, L Musset, P Cacoub, L Frangeul, D Vitour, T Poynard, P Opolon, D-T Nguyen, F Golliot, J-C Piette, J-M Huraux, and F Lunel
Gut 1999 45: 122-128.[Abstract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
